Stem Cells http://www.stemcellsportal.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online November 21, 2007
Stem Cells Vol. 26 No. 2 February 2008, pp. 422 -430
doi:10.1634/stemcells.2007-0641; www.StemCells.com
© 2008 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2007-0641v1
26/2/422    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoben, G. M.
Right arrow Articles by Athanasiou, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoben, G. M.
Right arrow Articles by Athanasiou, K. A.

EMBRYONIC STEM CELLS

Fibrochondrogenesis in Two Embryonic Stem Cell Lines: Effects of Differentiation Timelines

Gwendolyn M. Hobena,b, Eugene J. Koaya,b, Kyriacos A. Athanasioua

aDepartment of Bioengineering, Rice University, Houston, Texas, USA;
bBaylor College of Medicine, Houston, Texas, USA

Key Words. Fibrocartilage • Human embryonic stem cells • Tissue engineering

Correspondence: Kyriacos A. Athanasiou, Ph.D., P.E., Rice University, Department of Bioengineering, MS-142, P.O. Box 1892, Houston, Texas 77251-1892, USA. Telephone: 713-348-6385; Fax: 713-348-5877; e-mail: athanasiou{at}rice.edu

Received August 6, 2007; accepted for publication November 10, 2007.
First published online in STEM CELLS EXPRESS   November 21, 2007.



Human embryonic stem cells (hESCs) are an exciting cell source for fibrocartilage engineering. In this study, the effects of differentiation time and cell line, H9 versus BG01V, were examined. Embryoid bodies (EBs) were fibrochondrogenically differentiated for 1, 3, or 6 weeks and then used to engineer tissue constructs that were grown for an additional 4 weeks. Construct matrix was fibrocartilaginous, containing glycosaminoglycans (GAGs) and collagens I, II, and VI. A differentiation time of 3 or 6 weeks produced homogeneous constructs, with matrix composition varying greatly with cell line and differentiation time: from 2.6 to 17.4 µg of GAG per 106 cells and from 22.3 to 238.4 µg of collagen per 106 cells. Differentiation for 1 week resulted in small constructs with poor structural integrity that could not be mechanically tested. The compressive stiffness of the constructs obtained from EBs differentiated for 3 or 6 weeks did not vary significantly as a function of either differentiation time or cell line. In contrast, the tensile properties were markedly greater with the H9 cell line, 1,562–1,940 versus 32–80 kPa in the BG01V constructs. These results demonstrate the dramatic effects of hESC line and differentiation time on the biochemical and functional properties of tissue-engineered constructs and show progress in fibrocartilage tissue engineering with an exciting new cell source.

Disclosure of potential conflicts of interest is found at the end of this article.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2008 by AlphaMed Press.